Labels
Breast Cancers
(147)
Genitourinary Cancers
(73)
Lung Cancers
(73)
Gastrointestinal Cancers
(67)
Gynecological Cancers
(56)
Head and Neck Cancers
(50)
Cutaneous Cancers
(21)
Central Nervous System Cancers
(11)
Tuesday, 30 April 2013
European Medicines Agency recommends granting a conditional marketing authorisation for vismodegib
The European Medicines Agency Committee for Medicinal Products for Human Use has adopted a positive opinion, recommending the granting of a conditional marketing authorisation for the medicinal product vismodegib (Erivedge) 150 mg, hard capsule, intended for the treatment of adult patients with symptomatic metastatic basal cell carcinoma or locally advanced basal cell carcinoma inappropriate for surgery or radiotherapy. Read more here.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment